Logos Global Management’s Tango Therapeutics TNGX Stock Holding History

Logos Global Management’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$62.8M	Sell	3,000,000 -1,200,000	-29%	-$16.7M	3.13%	8
2025 Q4	$37.2M	Buy	4,200,000 +3,250,000	+342%	+$28M	2.25%	13
2025 Q3	$7.98M	Buy	+950,000	New	+$6.43M	0.72%	37
2021 Q3	–	Sell	-200,000	Closed	-$2.28M	–	67
2021 Q2	$2.28M	Hold	200,000	–	–	0.19%	49
2021 Q1	$2.22M	Hold	200,000	–	–	0.22%	48
2020 Q4	$2.29M	Hold	200,000	–	–	0.2%	49
2020 Q3	$2.07M	Buy	+200,000	New	+$2.04M	0.27%	43

Other funds holding TNGX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Logos Global Management's TNGX Position: Q1 2026 in Review

Logos Global Management reduced its Tango Therapeutics (TNGX) stake by 29% in Q1 2026, selling an estimated $16.7M and leaving 3,000,000 shares worth $62.8M. The position accounts for 3.13% of the portfolio, ranked #8.

Logos Global Management first reported a position in TNGX in Q3 2020 and has held it in 7 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

Logos Global Management held 3,000,000 shares of Tango Therapeutics worth $62.8M as of Q1 2026.
Logos Global Management sold 1,200,000 Tango Therapeutics shares in Q1 2026, an estimated $16.7M.
Tango Therapeutics made up 3.13% of Logos Global Management's portfolio in Q1 2026, its #8 holding.
Logos Global Management first reported a position in Tango Therapeutics in Q3 2020 and has held it in 7 quarters since.
194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Logos Global Management's 13F filing for Q1 2026, filed 15 May 2026.